Literature DB >> 11732774

Congenital hydranencephalic-hydrocephalic syndrome with proliferative vasculopathy: a possible relation with mitochondrial dysfunction.

M Castro-Gago1, E Pintos-Martínez, J Forteza-Vila, M Iglesias-Diz, R Ucieda-Somoza, I Silva-Villar, J Codesido-López, A Viso-Lorenzo, Y Campos, J Arenas, J Eirís-Puñal.   

Abstract

We report the case of a fetus aborted at gestation week 20 because of hydranencephalic-hydrocephalic syndrome. The fetus was the third pregnancy of a nonconsanguineous couple whose first child exhibited congenital hydranencephalic-hydrocephalic syndrome associated with muscle histology findings consistent with mitochondrial cytopathy and deficiency of complexes III and IV of the respiratory chain and whose second pregnancy had terminated in an elective abortion on detection of progressive hydrocephalus at gestation week 19. The third pregnancy had a normal course according to obstetric and ultrasonography examinations performed at gestation weeks 5, 10, and 15, and negative results were obtained in standard serologic and polymerase chain reaction (PCR) tests for prenatal infections of the mother. However, the ultrasonography examination at gestation week 18 revealed hydrocephalus, in response to which the parents requested an abortion, which was performed at gestation week 20; the fetus was male and with no evident external malformations. Histopathologic studies of the brain and medulla oblongata revealed proliferative vasculopathy (glomeruloid vessels, intracytoplasmic inclusions, and microcalcifications) and intracytoplasmic inclusions in the voluntary muscle. Microbiologic and PCR tests of hepatic and spleen tissue were negative for prenatal infections. In view of the precedent of a sister with mitochondrial dysfunction, these findings raise the pos sibility that at least some cases of familial syndrome of congenital hydranencephalic-hydrocephalic syndrome with proliferative vasculopathy can be attributed to alterations in the mitochondrial respiratory chain.

Entities:  

Mesh:

Year:  2001        PMID: 11732774     DOI: 10.1177/08830738010160111401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).

Authors:  Esther Meyer; Christopher Ricketts; Neil V Morgan; Mark R Morris; Shanaz Pasha; Louise J Tee; Fatimah Rahman; Anne Bazin; Bettina Bessières; Pierre Déchelotte; Mohamed T Yacoubi; Mudher Al-Adnani; Tamas Marton; David Tannahill; Richard C Trembath; Catherine Fallet-Bianco; Phillip Cox; Denise Williams; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

2.  The Fowler syndrome-associated protein FLVCR2 is an importer of heme.

Authors:  Simon P Duffy; Jennifer Shing; Punit Saraon; Lloyd C Berger; Maribeth V Eiden; Andrew Wilde; Chetankumar S Tailor
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

Review 3.  Genetics of human hydrocephalus.

Authors:  Jun Zhang; Michael A Williams; Daniele Rigamonti
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

Review 4.  Mitochondrial Targeting in Neurodegeneration: A Heme Perspective.

Authors:  Veronica Fiorito; Deborah Chiabrando; Emanuela Tolosano
Journal:  Pharmaceuticals (Basel)       Date:  2018-09-18

Review 5.  Unraveling the Role of Heme in Neurodegeneration.

Authors:  Deborah Chiabrando; Veronica Fiorito; Sara Petrillo; Emanuela Tolosano
Journal:  Front Neurosci       Date:  2018-10-09       Impact factor: 4.677

6.  MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme.

Authors:  Yingzhong Li; Nikola A Ivica; Ting Dong; Dimitrios P Papageorgiou; Yanpu He; Douglas R Brown; Marianna Kleyman; Guangan Hu; Walter W Chen; Lucas B Sullivan; Amanda Del Rosario; Paula T Hammond; Matthew G Vander Heiden; Jianzhu Chen
Journal:  Nat Commun       Date:  2020-09-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.